Health Care [ 7/12 ] | Pharmaceuticals [ 40/74 ]
NASDAQ | Common Stock
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules for delivery of polypeptides.
The company's product portfolio includes ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes, as well as in phase II clinical trial for the treatment of non-alcoholic steatohepatitis; and ORA-D-013-1 and ORA-D-013-2, which have completed phase II clinical trial for the treatment of type 2 diabetes.
It has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses.
Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 7, 24 | -0.48 Decreased by -1.30 K% | 0.04 Decreased by -1.30 K% |
| Aug 8, 24 | 0.26 Decreased by -21.21% | 0.01 Increased by +2.50 K% |
| Aug 8, 24 | 0.04 Decreased by -87.50% | 0.01 Increased by +300.00% |
| May 9, 24 | 0.04 Increased by +150.00% | 0.02 Increased by +100.00% |
| May 9, 24 | 0.04 Increased by +150.00% | 0.02 Increased by +100.00% |
| Mar 6, 24 | 0.33 Increased by +1.20 K% | -0.12 Increased by +375.00% |
| Feb 28, 24 | 0.32 Increased by +1.17 K% | -0.12 Increased by +366.67% |
| Nov 10, 23 | -0.08 Increased by 0.00% | -0.08 |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 0.00 Decreased by N/A% | -19.62 M Decreased by -247.11% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | 9.21 M Increased by +385.91% | Increased by +N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | 1.54 M Increased by +147.67% | Increased by +N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by -100.00% | 13.34 M Increased by +1.22 K% | Increased by +N/A% Increased by +N/A% |
| Nov 30, 23 | 0.00 Decreased by -100.00% | 13.34 M Increased by +1.22 K% | Increased by +N/A% Increased by +N/A% |
| Sep 30, 23 | 0.00 Decreased by -100.00% | -3.22 M Decreased by -79.20% | Decreased by N/A% Decreased by N/A% |
| Aug 31, 23 | 0.00 Decreased by -100.00% | -3.22 M Increased by +62.28% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 674.00 K Decreased by -1.03% | -1.19 M Increased by +86.02% | Decreased by -177.15% Increased by +85.88% |